Trial site
Galilee Medical Center
- 33running trials
- 17closed trials
The trials here
What the 50 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis9 trials
- Crohn's disease6 trials
- Chronic kidney disease3 trials
- Coronary artery disease3 trials
- Heart failure3 trials
- Multiple myeloma3 trials
- Obesity3 trials
- Stroke3 trials
- Type 2 diabetes3 trials
- Acute myeloid leukaemia2 trials
- Chronic lymphocytic leukaemia2 trials
- Follicular lymphoma2 trials
- and 22 more
- Phase
- Phase 332 trials
- Phase 27 trials
- Phase 2/33 trials
- Phase 1/22 trials
- Phase 41 trial
- Status
- Active, not recruiting17 trials
- Recruiting16 trials
- Completed15 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Janssen Research & Development, LLC10 trials
- Eli Lilly and Company8 trials
- Pfizer3 trials
- Regeneron Pharmaceuticals3 trials
- Takeda3 trials
- and 20 more
Running trials
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Recruiting
Recruiting
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
Evaluation of Microbial and Endocrinological Parameters in Dialysis Patients With Sepsis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- Crohn's disease2 recruiting
- Follicular lymphoma2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- Coronary artery disease1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- High blood pressure1 recruiting
- Iron deficiency anaemia1 recruiting
- Lupus (SLE)1 recruiting
- Peripheral artery disease1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Withdrawn
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Completed
Completed
Completed
Completed
Completed
Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Completed
Completed
Completed
Completed
Completed
Completed
Completed
COMMUNITY STUDY- A Study to Collect Information for the Cordio System
Site data: ClinicalTrials.govUpdated 18 Nov 2026